These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16814943)

  • 1. Enhanced scavenging of lipid substances is a possible effect of corticosteroids in the treatment of cholesterol crystal embolism.
    Cheng C; Tsuneyama K; Zheng H; Oya T; Cui Z; Feril LB; Takano Y
    Pathol Res Pract; 2006; 202(8):591-8. PubMed ID: 16814943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol crystal embolization (CCE): Improvement of renal function with high-dose corticosteroid treatment.
    Desai M; Ram R; Prayaga A; Dakshinamurty KV
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):327-30. PubMed ID: 21422636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol crystal embolization in the Netherlands.
    Moolenaar W; Lamers CB
    Arch Intern Med; 1996 Mar; 156(6):653-7. PubMed ID: 8629877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol crystal embolism syndrome in dialysis patients: an emerging clinical diagnosis?
    Piccoli GB; Fenoglio R; Colla L; Bilucaglia D; Mezza E; Burdese M; Bermond F; Segoloni GP
    Blood Purif; 2006; 24(5-6):433-8. PubMed ID: 16940713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary infection of Pneumocystis carinii and Cytomegalo virus in the treatment of cholesterol crystal embolism].
    Okuno A; Yamamoto R; Matsui I; Kitamura H; Fujita Y; Fujii M
    Nihon Jinzo Gakkai Shi; 2006; 48(5):416-20. PubMed ID: 16913463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of heparin and warfarin in the treatment of cholesterol crystal embolization.
    Wakabayashi T; Yoshizawa Y; Kawana S
    J Dermatol; 2008 Feb; 35(2):111-4. PubMed ID: 18271808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembolism.
    Ben-Horin S; Bardan E; Barshack I; Zaks N; Livneh A
    Am J Gastroenterol; 2003 Jul; 98(7):1471-9. PubMed ID: 12873565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat.
    Jeyakumar SM; Vajreswari A; Giridharan NV
    Obesity (Silver Spring); 2007 Feb; 15(2):322-9. PubMed ID: 17299104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
    Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
    Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression.
    Murao K; Yu X; Imachi H; Cao WM; Chen K; Matsumoto K; Nishiuchi T; Wong NC; Ishida T
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E78-87. PubMed ID: 17957039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
    Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case report of cholesterol crystal embolism 1 month after carotid stenting].
    Nakazawa K; Ohta T; Fujimoto M; Imamura H; Hashimoto N
    No Shinkei Geka; 2007 Aug; 35(8):807-11. PubMed ID: 17695780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel pleiotropic effect of atorvastatin on advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H
    Med Hypotheses; 2007; 69(2):338-40. PubMed ID: 17329034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
    Chen J; Huang L; Song M; Yu S; Gao P; Jing J
    J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endo arterial investigation: suspicious for the cholesterol crystal embolism disease].
    Fehri W; Lahidheb D; Bouladi W; Rahal N; Smiri Z; Barakett N; Hajlaoui N; Salah O; Mhenni H; Haouala H
    Tunis Med; 2007 Nov; 85(11):975-8. PubMed ID: 19166153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AGE/RAGE axis in diabetes-accelerated atherosclerosis.
    Jandeleit-Dahm K; Watson A; Soro-Paavonen A
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):329-34. PubMed ID: 18290873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Shen L
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.